Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 306 of 1,261
  1. US 11154557

    Antiviral prodrugs and nanoformulations thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  2. US 11154556

    Methods of treating solid tumors with CCR2 antagonists

    The Regents of the University of California · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  3. US 11154519

    Inhibitors and their uses

    United Kingdom Research and Innovation · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  4. US 11154494

    Programmable pharmaceutical compositions for chrono drug release

    Amneal Complex Products Research LLC · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  5. US 11155559

    Sulfonyl-substituted isoquinolines as inhibitors of RHO kinase and hERG potassium channel activity

    CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  6. US 11155633

    Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  7. US 11154636

    Antimicrobial biopolymer compositions, methods of synthesis, and applications of use

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  8. US 11155599

    Adenoviruses expressing heterologous tumor-associated antigens

    The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  9. US 11154572

    Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type

    The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  10. US 11154500

    Solid solution compositions and use in chronic inflammation

    Infirst Healthcare Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  11. US 11154602

    Cancer vaccines targeting mesothelin and uses thereof

    Inovio Pharmaceuticals, Inc. · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  12. US 11154574

    Tumor infiltrating lymphocytes and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  13. CA 3175580

    AGENTS IMMUNOSTIMULATEURS EN COMBINAISON AVEC DES INHIBITEURS DE L'ANGIOGENESE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Oct 21, 2021 · Expires Oct 16, 2041

    granted
  14. CA 3175356

    AGENTS IMMUNOSTIMULATEURS EN COMBINAISON AVEC DES INHIBITEURS DE L'ANGIOGENESE

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Oct 21, 2021 · Expires Oct 16, 2041

    granted
  15. US 11147770

    Pharmaceutical composition and administrations thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  16. US 11147844

    Methods of treatment of infections using bacteria

    Decoy Biosystems, Inc. · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  17. US 11147885

    ASH1L inhibitors and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  18. US 11149025

    Anti-cancer compounds

    The Regents of the University of California · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  19. US 11149273

    Lipid formulated compositions and methods for inhibiting expression of serum amyloid A gene

    Alnylam Pharmaceuticals, Inc. · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  20. US 11150237

    Patient-specific biomarkers of Escherichia coli invasion in inflammatory bowel disease

    The Regents of the University of California · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  21. US 11147946

    Venous access catheters and methods for portal venous system catheterization

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  22. US 11147837

    Modified cells and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  23. US 11147631

    System and method of performing treatment along a lumen network

    Covidien LP · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted
  24. US 11149020

    MAP kinase modulators and uses thereof

    Northwestern University · Granted Oct 19, 2021 · Expires Oct 14, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.